These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9513142)

  • 1. [Malarone: newcomer in the treatment of malaria].
    Touze JE; Fourcade L
    Med Trop (Mars); 1997; 57(3):225-7. PubMed ID: 9513142
    [No Abstract]   [Full Text] [Related]  

  • 2. [Atovaquone/proguanil. Prophylaxis and treatment of malaria].
    Lundgren JD; Dragsted UB
    Ugeskr Laeger; 2000 Jul; 162(31):4177-81. PubMed ID: 10962933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atovaquone-proguanil for falciparum malaria in the Philippines.
    Watt G
    J Infect Dis; 2000 Jan; 181(1):405. PubMed ID: 10608798
    [No Abstract]   [Full Text] [Related]  

  • 4. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
    Kuhn S; Gill MJ; Kain KC
    Am J Trop Med Hyg; 2005 Apr; 72(4):407-9. PubMed ID: 15827276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malarone: a new antimalarial for malaria chemoprevention].
    Delmont J
    Med Trop (Mars); 2002; 62(1):19-21. PubMed ID: 12038171
    [No Abstract]   [Full Text] [Related]  

  • 7. Atovaquone/proguanil for the prophylaxis and treatment of malaria.
    Patel SN; Kain KC
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):849-61. PubMed ID: 16307498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium falciparum outwits Malarone, protector of travellers.
    Crabb C
    Bull World Health Organ; 2003; 81(5):382-3. PubMed ID: 12856058
    [No Abstract]   [Full Text] [Related]  

  • 9. [What is the value of the combination atovaquone-proguanil for the clinician?].
    Delmont J
    Med Trop (Mars); 2002; 62(3):232-6. PubMed ID: 12244917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines.
    Bustos DG; Canfield CJ; Canete-Miguel E; Hutchinson DB
    J Infect Dis; 1999 Jun; 179(6):1587-90. PubMed ID: 10228090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [symbol: see text] Atovaquone + proguanil for malaria prophylaxis.
    Drug Ther Bull; 2001 Oct; 39(10):73-5. PubMed ID: 11706518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atovaquone/Proguanil (Malarone) for malaria.
    Med Lett Drugs Ther; 2000 Nov; 42(1093):109-11. PubMed ID: 11093830
    [No Abstract]   [Full Text] [Related]  

  • 13. Atovaquone-proguanil for prophylaxis and treatment of malaria.
    Marra F; Salzman JR; Ensom MH
    Ann Pharmacother; 2003 Sep; 37(9):1266-75. PubMed ID: 12921511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atovaquone and proguanil versus amodiaquine for the treatment of Plasmodium falciparum malaria in African infants and young children.
    Borrmann S; Faucher JF; Bagaphou T; Missinou MA; Binder RK; Pabisch S; Rezbach P; Matsiegui PB; Lell B; Miller G; Kremsner PG
    Clin Infect Dis; 2003 Dec; 37(11):1441-7. PubMed ID: 14614665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria prophylaxis for the 1990s and beyond.
    Whitty CJ
    Br J Hosp Med; 1997 Dec; 58(11):545-6. PubMed ID: 10193466
    [No Abstract]   [Full Text] [Related]  

  • 16. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
    Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
    Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
    Schwartz E; Bujanover S; Kain KC
    Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New strategies in therapy to roll back malaria].
    Kaiser A; Maier W
    Dtsch Med Wochenschr; 2002 Jul; 127(30):1595-600. PubMed ID: 12143016
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized open label clinical trial to compare the efficacy and safety of intravenous quinine followed by oral malarone vs. intravenous quinine followed by oral quinine in the treatment of severe malaria.
    Esamai F; Tenge CN; Ayuo PO; Ong'or WO; Obala A; Jakait B
    J Trop Pediatr; 2005 Feb; 51(1):17-24. PubMed ID: 15601653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens.
    Kain KC; Shanks GD; Keystone JS
    Clin Infect Dis; 2001 Jul; 33(2):226-34. PubMed ID: 11418883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.